Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 29Neoplasms 5Glioma 4Ovarian Neoplasms 3Neoplasm Metastasis 3Melanoma 3Glioblastoma 3Rhabdoid Tumor 2Neoplasms, Germ Cell and Embryonal 2Medulloblastoma 2Lymphoma 2Liposarcoma 2Fallopian Tube Neoplasms 2Diffuse Intrinsic Pontine Glioma 2Brain Neoplasms 2Astrocytoma 2Thymus Neoplasms 1Teratoma 1Solid Tumors Harboring a BRAF V600 Mutation 1Sarcoma, Synovial 1Sarcoma 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Pinealoma 1Osteitis Deformans 1Oligodendroglioma 1Non functioning pancreatic endocrine tumor 1Neurofibrosarcoma 1Neuroendocrine Tumors 1

Interventions

Doxorubicin 11Ifosfamide 9Radiotherapy 6Filgrastim 4pegfilgrastim 3Sorafenib 2Sirolimus 2Magnetic Resonance Spectroscopy 2Imatinib Mesylate 2Etoposide 2Chemotherapy, Adjuvant 2temsirolimus 1selinexor 1romidepsin 1ribociclib 1perifosine 1pazopanib 1lorvotuzumab mertansine 1liposomal doxorubicin 1indolepropanol phosphate 1exatecan 1cixutumumab 1brostallicin 1X-Rays 1Watchful Waiting 1Trabectedin 1Sunitinib 1Specimen Handling 1STA 9090 1Razoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neurofibrosarcoma × ribociclib × Clear all
NCT03009201 2023-08-16

Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery

OHSU Knight Cancer Institute

Phase 1 Completed
16 enrolled
Sarcoma

Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Disorders of Sex Development, Sarcoma, Synovial, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡